论文信息 - An open-label, Phase I study of cediranib (RECENTIN) in patients with acute myeloid leukemia. - 字舞流文

An open-label, Phase I study of cediranib (RECENTIN) in patients with acute myeloid leukemia.

M. Heuser | W. Berdel | H. Serve | W. Fiedler | G. Ehninger | U. Zirrgiebel | R. Mesters | T. Puchalski | J. Robertson | B. Collins | J. Jürgensmeier